Target-based anti-cancer drugs

• Kondo Shunsuke

  Department of medical oncology, National Cancer Center Hospital

• Saijo Nagahiro

  Department of medical oncology, National Cancer Center Hospital

Bibliographic Information

Other Title

• バイオ医薬によるターゲティング治療　　悪性腫ようとターゲティング療法
• 悪性腫瘍とターゲティング療法

Abstract

In twenty first century, some molecular target-based anticancer drugs have been available with our expectation. But there are many negative data in clinical trials contrary to our expectation. Further, they have induced severe adverse event that we did not expect. So we can accurately identify their molecular targets, and demonstrate their efficacy in clinical trials. It is essential to increase the population of well trained medical oncologists who can understand modern molecular biology in order to further improve the treatment results with target based anticancer therapy.

Journal

• Drug Delivery System

  Drug Delivery System 19 (2), 103-109, 2004

  THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM

Keywords

• target-bused therapy
• translational study
• clinical trials
• individualized therapy

Details

• CRID: 1390282679618298368
• NII Article ID: 10012844380
• NII Book ID: AN10084591
• DOI: 10.2745/dds.19.103
• ISSN: 18812732
• ISSN: 09135006
• Web Site: https://search.jamas.or.jp/link/ui/2004256140
• Text Lang: ja
• Data Source:
  • JaLC
  • Crossref
  • CiNii Articles
• Abstract License Flag: Disallowed